Hedge Funds Don’t Love Immunomedics, Inc. (IMMU) Anymore
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th. Among them, Facebook and......(read more)
Posts Tagged ‘NASDAQ:IMMU’
Hedge Fund and Insider Trading News: David Tepper, Joel Greenblatt, Seth Klarman, Bain Capital, Dollar Tree, Inc. (DLTR), Carnival PLC (CUK), and More
Hedge Funds and Bad Tactics Kill $4.4 Billion Deal (Bloomberg) The heated auction between buyout firm Bain Capital and Austria’s AMS AG for the German......(read more)
Hedge Fund and Insider Trading News: Bill Ackman, Citadel LLC, Hemispherx Biopharma Inc (HEB), Gold Resource Corporation (GORO), Immunomedics Inc (IMMU), and More
Hedge Fund Citadel Executes Cleared Cash and Repo Trades Through DTCC (Global Custodian) Hedge fund giant Citadel has executed and cleared both cash Treasury......(read more)
Hedge Fund and Insider Trading News: Kyle Bass, Mike Novogratz, Aurelius Capital, Hemispherx Biopharma Inc (HEB), Lowe’s Companies, Inc. (LOW), and More
Hedge Fund Manager Kyle Bass Says the US has More Leverage Over China than Ever Before (CNBC) Hedge fund manager Kyle Bass believes the United States......(read more)
Is Immunomedics, Inc. (IMMU) A Good Stock To Buy?
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Tiger Global because we determined......(read more)
Hedge Funds Are Selling Immunomedics, Inc. (IMMU)
The government requires hedge funds and wealthy investors with over a certain portfolio size to file a report that shows their positions at the end of......(read more)
13D Filing: VenBio Select Advisor and Immunomedics Inc (IMMU)
Immunomedics Inc (NASDAQ:IMMU): Behzad Aghazadeh’s VenBio Select Advisor filed an amended 13D. You can check out VenBio Select Advisor’s latest......(read more)
13D Filing: VenBio Select Advisor and Immunomedics Inc (IMMU)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 6 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
35 Fresh Stories That You Should Read To Know How The Financial Markets Are Doing Today
1. U.S. Stock Market: “U.S. stocks slipped Monday, as declining prices for industrial metals weighed on materials shares. The Dow Jones Industrial......(read more)
Financial Markets Snapshot: Today’s 35 Major Stories from the World of Finance
1. U.S. Stock Market: “U.S. stocks struggled to hold on to slight gains Friday, flipping in and out of negative territory, as investors weighed......(read more)
These 34 Stories Can Tell You What’s Happening In The Finance World Today
1. US Stock Market: “U.S. stocks recovered from lows of the day Friday afternoon, but were struggling to trade in positive territory, as President......(read more)
13D Filing: VenBio Select Advisor and Immunomedics Inc (NASDAQ:IMMU)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 5 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
Here’s What’s Moving Immunomedics, Inc. (IMMU) And Ocera Therapeutics Inc (OCRX)
Yet again we’ve had a pretty busy week in the biotech space. Macro forces are coming in to play, and combined with what proved a busy release calendar......(read more)
Here’s Our Take On The Immunomedics, Inc. (IMMU) Deal
Immunomedics, Inc. (NASDAQ:IMMU) was a big winner towards the end of last week, as the company put out news that it had scored a deal with fellow biotech......(read more)
Does Immunomedics, Inc. (IMMU)’s New Candidate IMMU-140 Stand A Chance Of Success?
Immunomedics, Inc. (NASDAQ:IMMU) has a new drug candidate called IMMU-140 that is based on its antibody-drug conjugate (ADC) program. The company took......(read more)
Immunomedics, Inc. (IMMU): The Smart Money Is Quietly Loading Up On This Stock
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers......(read more)
Why Are These Stocks Deep in Red Today?
The three major indexes are slightly in the green today after Federal Reserve Chairwoman Janet Yellen said that the institution would take a cautious......(read more)
Why Adamis Pharmaceuticals, Immunomedics and Three Other Stocks Are Deep in Red Today?
Markets are trading higher on Monday, as HSBC Holdings PLC said in a report earlier today that the markets are poised to remain bullish. However, some......(read more)
Why Are These Stocks Deep in the Red Today?
Despite the unemployment rate falling to 4.7%, all three indexes are in the red this morning after the Labor Department reported that nonfarm payrolls......(read more)
Is Immunomedics, Inc. (IMMU) A Good Stock To Buy?
At Insider Monkey, we pore over the filings of more than 700 top investment firms every quarter, a process we have now completed for the latest reporting......(read more)
Anika Therapeutics, Inc. (ANIK) Stands out Over Competition
Anika Therapeutics, Inc. (NASDAQ:ANIK) has quietly gone from being a complete unknown to recently being picked up by six hedge fund managers. This is......(read more)
Immunomedics, Inc. (IMMU), ImmunoGen, Inc. (IMGN): Should You Invest in These Cancer Treatment Biotechs?
Today, cancer is the second leading cause of death in the United States, accounting for nearly a quarter of all deaths in the country. 1.7 million new......(read more)
Hedge Funds Are Betting On Anika Therapeutics, Inc. (ANIK)
Anika Therapeutics, Inc. (NASDAQ:ANIK) was in 7 hedge funds’ portfolio at the end of the first quarter of 2013. ANIK investors should pay attention......(read more)
Omthera Pharmaceuticals Inc (OMTH), GlaxoSmithKline plc (ADR) (GSK): This Week in Biotech
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......(read more)
Biogen Idec Inc. (BIIB), Pharmacyclics, Inc. (PCYC), Immunomedics, Inc. (IMMU), and Tackling Cancer, Non-Hodgkin Lymphoma’s Biggest Current & Upcoming Players
As I noted seven weeks ago, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing......(read more)
